Reproductive BioMedicine Online
Volume 22, Issue 1 , Pages 59-64 , January 2011

Vascular endothelial growth factor gene polymorphisms in North Indian patients with recurrent miscarriages

Received 19 April 2010 ,Revised 29 June 2010 ,Accepted 17 August 2010.

References 

  1. Awata T, Inoue K, Kurihara S, et al. A common polymorphism in the 5’Untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes. 2002;51:1635–1639
  2. Brogan IJ, Khan N, Isaac K, Hutchinson JA, Pravica V, Hutchinson IV. Novel polymorphisms in the promoter and 5’UTR regions of the human vascular endothelial growth factor gene. Hum. Immunol. 1999;60:1245–1249
  3. Buraczynska M, Ksiazek P, Gaszczyk IB, Jozwiak L. Association of the VEGF gene polymorphism with diabetic retinopathy in type 2 diabetes patients. Nephrol. Dial. Transplant. 2007;22:827–832
  4. Coulam CB, Jeyendran RS. Vascular endothelial growth factor gene polymorphisms and recurrent pregnancy loss. Am. J. Reprod. Immunol. 2008;59:301–305
  5. Ferrara N, Gerber HP, Couter JL. The biology of VEGF and its receptors. Nature. 2003;9:669–676
  6. Goodman C, Jeyendran RS, Coulam CB. Vascular endothelial growth factor gene polymorphism and implantation failure. Reprod. Biomed. Online. 2008;16:720–723
  7. Goodman, C., Jeyendran, R.S., Coulam, C.B., in press. P53 tumor suppressor factor, plasminogen activator inhibitor, and vascular endothelial growth factor gene polymorphisms and recurrent implantation failure. Fertil. Steril.
  8. Lee, H.H., Hong, S.H., Shin, S.J., Ko, J.J., Oh, D., Kim, N.K., 2009. Association study of vascular endothelial growth factor polymorphisms with the risk of recurrent spontaneous abortion. Fertil. Steril. Jan 6. [Epub ahead of print].
  9. Li Z, Zhang Y, Ying Ma J, et al. Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia. Hypertension. 2007;50:686–692
  10. Molskness TA, Stouffer RL, Burry KA, Gorrill MJ, Lee DM, Patton PE. Circulating levels of free and total vascular endothelial growth factor (VEGF)-A, soluble VEGF receptors-1 and -2, and angiogenin during ovarian stimulation in non-human primates and women. Hum. Reprod. 2004;19:822–830
  11. Nardo LG. Vascular endothelial growth factor expression in the endometrium during the menstrual cycle, implantation window and early pregnancy. Curr. Opin. Obstet. Gynecol. 2005;17:419–423
  12. Norwitz ER. Defective implantation and placentation: laying the blueprint for pregnancy complications. Reprod. Biomed. Online. 2006;13:591–599
  13. Papazoglou D, Galazios G, Koukourakis MI, Panagopoulos I, Kontomanolis EN, Papatheodorou K. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol. Hum. Reprod. 2004;10:321–324
  14. Papazoglou D, Galazios G, Papatheodorou K, et al. Vascular endothelial growth factor gene polymorphisms and idiopathic recurrent pregnancy loss. Fertil. Steril. 2005;83:959–963
  15. Prior SJ, Hagberg JM, Paton CM, et al. DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption. Am. J. Physiol. Heart Circ. Physiol. 2006;290:1848–1855
  16. Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J. Vasc. Res. 2000;37:443–448
  17. Salvarani C, Boiardi L, Casali B, et al. Vascular endothelial growth factor gene polymorphisms in Behçet’s disease. J. Rheumatol. 2004;31:1785–1789
  18. Shahbazi M, Fryer AA, Pravica V, et al. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J. Am. Soc. Nephrol. 2002;13:260–264
  19. Torry DS, Hinrichs M, Torry RJ. Determinants of placental vascularity. Am. J. Reprod. Immunol. 2004;51:257–268
  20. Uthra S, Raman R, Mukesh BN, et al. Association of VEGF gene polymorphisms with diabetic retinopathy in a South Indian cohort. Ophthalmic Genet. 2008;29:11–15
  21. Vuorela P, Carpen O, Tulppala M, Halmesmäki E. VEGF, its receptors and the tie receptors in recurrent miscarriage. Mol. Hum. Reprod. 2000;6:276–282

 Prof Suraksha Agrawal obtained her PhD from Punjab University, India, in 1977. Her fields of interest are immunobiology of reproduction, Immunogenetics, cancer and population genetics. She has published over 150 national and international papers, three books and over 15 chapters in different books. She has been associated with the Sanjay Gandhi Post Graduate Institute of Medical Sciences since its inception and has been looking after the immunogenetics laboratory since 1988. She was also the chairperson of the department from 1997 to 2009.

PII: S1472-6483(10)00552-3

doi: 10.1016/j.rbmo.2010.08.005

Reproductive BioMedicine Online
Volume 22, Issue 1 , Pages 59-64 , January 2011

Article Tools